# Gennex Laboratories Ltd (GENNEX)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹10.95
Day Change: +0.11%
52W High: ₹17.25
52W Low: ₹7.05
Market Cap: ₹231 Cr

## Valuation
P/E: 13.04
P/B: 1.08
EPS: ₹0.73
Book Value: ₹8.78
Dividend Yield: 0%

## Returns
1Y Return: -16.41%

## Profitability
ROE: 22.78%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Gennex Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Gennex Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
- Announcement: Shareholder Meeting / Postal Ballot-Outcome of EGM
- BSE Filing: Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

## Access
Current tier: anonymous
More history: Register free to see 6 more years.

## Data Freshness
Quote Updated: 2026-05-21T07:30:20.164Z
Price History Updated: 2026-05-25T05:43:43.258Z
Latest Price History Date: 2026-05-21
Technicals Updated: 2026-05-25T05:43:43.258Z
Quant Updated: 2026-05-25T05:43:43.258Z
Sentiment Updated: 2026-05-25T05:43:43.258Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2018)
Revenue: ₹42 Cr
Operating Profit: ₹5 Cr (OPM 11%)
Net Profit: ₹3 Cr
Tax: ₹3 Cr

## Annual P&L History
Mar 2018: Rev ₹42Cr | PAT ₹3Cr | OPM 11%
Mar 2019: Rev ₹44Cr | PAT ₹1Cr | OPM 5%
Mar 2020: Rev ₹56Cr | PAT ₹2Cr | OPM 7%

## Balance Sheet (Mar 2018)
Total Assets: ₹49 Cr
Total Liabilities: ₹49 Cr
Borrowings: ₹4 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/gennex
Disclaimer: For research and education only. Not investment advice.